Moore JP - Search Results

1

HIV vaccine design and the neutralizing antibody problem.

Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT. Burton DR, et al. Among authors: moore jp. Nat Immunol. 2004 Mar;5(3):233-6. doi: 10.1038/ni0304-233. Nat Immunol. 2004. PMID: 14985706 No abstract available.

2

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.

Healey D, Dianda L, Moore JP, McDougal JS, Moore MJ, Estess P, Buck D, Kwong PD, Beverley PC, Sattentau QJ. Healey D, et al. Among authors: moore jp, moore mj. J Exp Med. 1990 Oct 1;172(4):1233-42. doi: 10.1084/jem.172.4.1233. J Exp Med. 1990. PMID: 1698911 Free PMC article.

3

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.

Moore JP, Sattentau QJ, Wyatt R, Sodroski J. Moore JP, et al. J Virol. 1994 Jan;68(1):469-84. doi: 10.1128/JVI.68.1.469-484.1994. J Virol. 1994. PMID: 7504741 Free PMC article.

4

Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assays.

Moore JP, Cao Y, Conley AJ, Wyatt R, Robinson J, Gorny MK, Zolla-Pazner S, Ho DD, Koup RA. Moore JP, et al. J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):332-9. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7510807

5

Antigenic variation in gp120s from molecular clones of HIV-1 LAI.

Moore JP, Yoshiyama H, Ho DD, Robinson JE, Sodroski J. Moore JP, et al. AIDS Res Hum Retroviruses. 1993 Dec;9(12):1185-93. doi: 10.1089/aid.1993.9.1185. AIDS Res Hum Retroviruses. 1993. PMID: 7511394

6

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

Roben P, Moore JP, Thali M, Sodroski J, Barbas CF 3rd, Burton DR. Roben P, et al. Among authors: moore jp. J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994. J Virol. 1994. PMID: 7518527 Free PMC article.

7

Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.

Kang CY, Hariharan K, Nara PL, Sodroski J, Moore JP. Kang CY, et al. Among authors: moore jp. J Virol. 1994 Sep;68(9):5854-62. doi: 10.1128/JVI.68.9.5854-5862.1994. J Virol. 1994. PMID: 7520095 Free PMC article.

8

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.

Gorny MK, Moore JP, Conley AJ, Karwowska S, Sodroski J, Williams C, Burda S, Boots LJ, Zolla-Pazner S. Gorny MK, et al. Among authors: moore jp. J Virol. 1994 Dec;68(12):8312-20. doi: 10.1128/JVI.68.12.8312-8320.1994. J Virol. 1994. PMID: 7525987 Free PMC article.

9

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.

Moore JP, Cao Y, Qing L, Sattentau QJ, Pyati J, Koduri R, Robinson J, Barbas CF 3rd, Burton DR, Ho DD. Moore JP, et al. J Virol. 1995 Jan;69(1):101-9. doi: 10.1128/JVI.69.1.101-109.1995. J Virol. 1995. PMID: 7527081 Free PMC article.

10

Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.

Ditzel HJ, Binley JM, Moore JP, Sodroski J, Sullivan N, Sawyer LS, Hendry RM, Yang WP, Barbas CF 3rd, Burton DR. Ditzel HJ, et al. Among authors: moore jp. J Immunol. 1995 Jan 15;154(2):893-906. J Immunol. 1995. PMID: 7529290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

750 results

Search Page